On the fly News and insights, exclusive to thefly.com

WMT

Walmart

$144.40 /

+2.7 (+1.91%)

, RLI

RLI Corp.

$107.45 /

+5.1 (+4.98%)

09:54
10/19/21
10/19
09:54
10/19/21
09:54

Fly Intel: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Walmart (WMT) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Kate McShane saying after the recent stock underperformance, the company is in a position to take share and "do it more profitably" into 2022. 2. RLI Corp. (RLI) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Meyer Shields expecting the "significant profitability" embedded in the company's book value, "persistent" reserve releases and intelligent cycle management in the "still-rising" rate environment to drive earnings outperformance over the next 12 months. 3. Albemarle (ALB) upgraded to Outperform from Sector Perform at RBC Capital with analyst Arun Viswanathan saying the company should continue to benefit from accelerating production growth of electric vehicles given its unique low cost position and global scale. 4. Skechers (SKX) upgraded to Buy from Hold at Williams Capital with analyst Sam Poser saying given its "supply chain prowess," Skechers has been overcoming, and will continue to overcome, supply chain constraints "better than almost every company in the footwear space." 5. Indaptus Therapeutics (INDP) upgraded to Buy from Hold at Maxim with analyst Jason McCarthy saying the company is leveraging the ability of attenuated, non-pathogenic gram-negative bacteria to stimulate both innate and adaptive immune responses for oncology indications and infectious diseases while building on the success of the world's original immune therapy. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

WMT

Walmart

$144.40 /

+2.7 (+1.91%)

RLI

RLI Corp.

$107.45 /

+5.1 (+4.98%)

ALB

Albemarle

$241.75 /

+4.83 (+2.04%)

SKX

Skechers

$44.27 /

+0.605 (+1.39%)

INDP

Indaptus Therapeutics

$7.98 /

+0.42 (+5.56%)

  • 21

    Oct

  • 21

    Oct

  • 28

    Oct

  • 04

    Nov

  • 01

    Dec

  • 04

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.